The second Trump administration is beginning to take shape. Miller is expected to take on a larger role in Trump’s second term, and has said that Trump will “seek a tenfold increase in the ...

The UK medicines regulator approved Eli Lilly's Alzheimer's disease therapy Kisunla today, but the drug is too expensive to be funded by the NHS, according to cost-effectiveness watchdog NICE.

Nordic is the leader in Bluetooth Low Energy, a market with double-digit growth rates where Nordic enjoys 40% market share. Nordic’s top-line growth should remain healthy in the next decade.